Interestingly, it is important to note that most of the mutations identified in HS patients affect the N-terminal domain of CCBE1, in contrast with the only two mutations found at the C-terminal (collagen domains) (Roukens et al., 2015). Here, CCBE1 is linked to histiocytic sarcoma.